Newsletter | April 30, 2019

04.30.19 -- Inside NIIMBL's Tech Roadmap For Gene Therapy Manufacturing

 

Hello Cell & Gene Readers:

 

In November 2018, NIIMBL published technology roadmaps addressing needs and gaps in three key product areas: gene therapy, antibody-drug conjugates, and vaccines. This piece highlights technology opportunities for gene therapy manufacturing.

 

ASGCT’s 22nd Annual Meeting is in full swing. The meeting began yesterday and will continue through 12:15 pm on Thursday, May 2, 2019. Exhibits began yesterday and will run through Wednesday, May 1. Here’s a brief synopsis of what to expect at the Society’s highly anticipated event.

 

Erin Harris, editor in chief
Follow me on Twitter

Industry Insights
Scalable Process For Adenovirus Production
Application Note | GE Healthcare Life Sciences

This application note describes a process for adenovirus production, from upstream cell culture to downstream purification, using modern tools and technologies. 

Connect With Cell & Gene:
      Twitter